Polyclonal Antibody to Placenta Growth Factor (PLGF) Rattus norvegicus (Rat) Polyclonal antibody

PlGF2; PGF; PGFL; Placental Growth Factor-Like; Vascular Endothelial Growth Factor-Related Protein

Add to Cart Distributors
Overview
Properties
  • SourcePolyclonal antibody preparation, Host Rabbit
  • Ig Type IgG, Potency n/a
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Immunogen RPA114Ra01-Recombinant Placenta Growth Factor (PLGF)
  • Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  • TraitsLiquid, Concentration 500µg/mL
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Polyclonal Antibody to Placenta Growth Factor (PLGF) Packages (Simulation)
  • Polyclonal Antibody to Placenta Growth Factor (PLGF) Packages (Simulation)
  • Polyclonal Antibody to Placenta Growth Factor (PLGF) Vector Red staining on IHC-P; Samples: Human Placenta Tissue; Primary Ab: 20µg/ml Rabbit Anti-Human PLGF Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
  • PAA114Ra01.jpg Figure. Western Blot; Sample: Recombinant PLGF, Rat.
  • Polyclonal Antibody to Placenta Growth Factor (PLGF) Western Blot; Sample: Rat Placenta lysate
    Primary Ab: 0.2µg/ml Rabbit Anti-Rat PLGF Antibody
    Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specifity

The antibody is a rabbit polyclonal antibody raised against PLGF. It has been selected for its ability to recognize PLGF in immunohistochemical staining and western blotting.

Usage

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Giveaways

Citations

  • Mutant hypoxia inducible factor-1α improves angiogenesis and tissue perfusion in ischemic rabbit skeletal muscle PubMed: 20937289
  • Elevated PLGF contributes to small-cell lung cancer brain metastasisPubMed: 22797069
  • Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1PubMed: PMC3687373
  • Sustained dual release of placental growth factor-2 and bone morphogenic protein-2 from heparin-based nanocomplexes for direct osteogenesisPubmed:27042064
  • Serum angiogenic profile in abnormal placentationPubmed:26863111
  • Administration of atosiban in patients with endometriosis undergoing frozen–thawed embryo transfer: a prospective, randomized studyPubmed:27143518
  • Placental Growth Factor Triggers Epithelial-to-Mesenchymal Transition-like Changes in Rat Type II Alveolar Epithelial Cells: Activation of Nuclear Factor κB Signalling Pathwaydoi:10.1111
  • Placenta growth factor contributes to cell apoptosis and epithelial-to-mesenchymal transition in the hyperoxia-induced acute lung injuryPubmed:27211521
  • Knockdown of placental growth factor (PLGF) mitigates hyperoxia-induced acute lung injury in neonatal rats: Suppressive effects on NFκB signaling pathwayPubmed:27280587
  • Relationship between elevated serum level of placental growth factor and status of gestational diabetes mellitusPubmed: 30935303
  • sFlt-1/PlGF Ratio in Prediction of Short-Term Neonatal Outcome of Small for Gestational Age Neonates34438609
  • Puerarin Reduces Radiation-Induced Vascular Endothelial Cell Damage Via miR-34a/Placental Growth FactorPubmed:35110976

Recommend products